| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 122 |
| 1 | METFORMIN ER 500 MG | 88 |
| 2 | METFORMIN ER 750 MG | 88 |
| 3 | METFORMIN HYDROCHLORIDE | 37 |
| 4 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 34 |
| 5 | METFORMIN HYDROCHLORIDE TABLET | 34 |
| 6 | METFORMIN HYDROCHLORIDE TABLETS | 34 |
| 7 | TACROLIMUS | 33 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 33 |
| 9 | TACROLIMUS OINTMENT 0.1% | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-ARGININE | 2 | 0.0056 |
| 1 | TAURINE | 2 | 0.0027 |
| 2 | MIGALASTAT HYDROCHLORIDE | 1 | 0.0018 |
| 3 | SIROLIMUS | 19 | 0.0014 |
| 4 | LEVOCARNITINE | 3 | 0.0008 |
| 5 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 6 | FOSPHENYTOIN SODIUM | 2 | 0.0008 |
| 7 | METFORMIN HYDROCHLORIDE | 37 | 0.0006 |
| 8 | METFORMIN HYDROCHLORIDE TABLETS | 34 | 0.0006 |
| 9 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 34 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 20 |
| 1 | Kinase Inhibitor [EPC] | 20 |
| 2 | mTOR Inhibitor Immunosuppressant [EPC] | 20 |
| 3 | Mood Stabilizer [EPC] | 18 |
| 4 | Sulfonylurea [EPC] | 18 |
| 5 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 17 |
| 6 | Insulin Analog [EPC] | 11 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 10 |
| 8 | Benzodiazepine [EPC] | 8 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 3 | 0.0008 |
| 1 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 17 | 0.0005 |
| 2 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 4 | 0.0005 |
| 3 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Sulfonylurea [EPC] | 18 | 0.0001 |
| 5 | Anti-epileptic Agent [EPC] | 20 | 0.0001 |
| 6 | Mood Stabilizer [EPC] | 18 | 0.0001 |
| 7 | General Anesthetic [EPC] | 3 | 0.0001 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 5 | 0.0001 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 7 | 0.0001 |